 |
Amifostine |
|---|---|
| Trade Name | Ethyol |
| Orphan Indication | For use as a chemoprotective agent for cisplatin in the treatment of advanced ovarian carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1990-05-30 00:00:00 |
| Sponsor | Medimmune Oncology, Inc.;One Tower Bridge, 100 Front St., Suite 400;West Conshohocken, Pennsylvania, 19428 |
